THE DIFFERENCES IN PROGNOSTIC OUTCOME BETWEEN AML1/ETO AND CBFβ/MYH11 POSITIVE AML PATIENTS

被引：0
|
作者：
Markova, J. [1 ]
Michkova, P. [1 ]
Maaloufova, J. Soukupova [1 ]
Soukup, P. [1 ]
Cetkovsky, P. [1 ]
Schwarz, J. [1 ]
机构：
[1] Inst Hematol & Blood Transfus, Prague, Czech Republic
来源：
HAEMATOLOGICA | 2012年 / 97卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0669
引用
收藏
页码：273 / 274
页数：2
相关论文
共 50 条
  • [21] Incidence of AML1/ETO fusion transcripts in patients entered into the MRC AML trials
    Langabeer, SE
    Walker, H
    Rogers, JR
    Burnett, AK
    Wheatley, K
    Swirsky, D
    Goldstone, AH
    Linch, DC
    BRITISH JOURNAL OF HAEMATOLOGY, 1997, 99 (04) : 925 - 928
  • [22] Kinetics of MRD in AML with INV(16) monitored by CBF beta/MYH11 RT-PCR
    Novak, M
    Laczika, K
    Mitterbauer, M
    ScheidelPetrovic, A
    Greinix, H
    Fridrik, M
    Haas, OA
    Lechner, K
    Jaeger, U
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 835 - 835
  • [23] Real time RT-PCR for the detection and quantification of CBFβ/MYH11 fusion transcripts in INV(16) positive AML.
    Hoellge, W
    Wattjes, M
    Nagel, S
    Doden, M
    Krug, U
    Ganser, A
    Heil, G
    BLOOD, 1999, 94 (10) : 207B - 207B
  • [24] Different cooperating mutation patterns of receptor tyrosine kinases/Ras/JAK2 between de novo AML1-ETO and CBFβ-MYH11 acute myeloid leukemia
    Liang, Der-Cherng
    Shih, Lee-Yung
    Huang, Chein-Fuang
    Lai, Chang-Liang
    Chang, Ya-Tzu
    Lin, Tung-Huei
    Wu, Jin-Hou
    Kou, Ming-Chung
    Lin, Tung-Liang
    Yang, Chao-Ping
    Liu, Hsu-Che
    BLOOD, 2007, 110 (11) : 1021A - 1021A
  • [25] Detection and quantitation of MYH11/CBF beta transcripts in presentation and follow up samples from AML patients with INV(16).
    Evans, PAS
    Norfolk, DR
    Child, JA
    Shiach, CR
    Short, M
    Jack, A
    Tobal, K
    Yin, JAL
    Morgan, GJ
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 236 - 236
  • [26] Comparison of karyotype analysis and RT PCR for AML1/ETO in 204 unselected patients with AML
    Mitterbauer, M
    Kusec, R
    Schwarzinger, I
    Haas, OA
    Lechner, K
    Jaeger, U
    ANNALS OF HEMATOLOGY, 1998, 76 (3-4) : 139 - 143
  • [27] PROTEOMIC MODIFICATIONS INDUCED BY AZACITIDINE IN AML1/ETO POSITIVE LEUKEMIA CELLS
    Santini, V.
    Buchi, F.
    Ferrari, G.
    Spinelli, E.
    Lunghi, T.
    Gozzini, A.
    Bosi, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 207 - 207
  • [28] Quantification of CBF beta/MYH11 fusion transcripts by competitive RT-PCR potentially predicts patient outcome in AML with inv(16).
    Novak, M
    Laczika, K
    Hilgarth, B
    ScheidelPetrovic, A
    Mitterbauer, M
    Lechner, K
    Jaeger, U
    BLOOD, 1996, 88 (10) : 2236 - 2236
  • [29] Comparison of karyotype analysis and RT-PCR for AML1/ETO in 204 unselected patients with AML
    M. Mitterbauer
    R. Kusec
    I. Schwarzinger
    O. A. Haas
    K. Lechner
    U. Jaeger
    Annals of Hematology, 1998, 76 : 139 - 143
  • [30] Detection and quantitation of the CBFβ/MYH11 transcripts associated with the inv(16) in presentation and follow-up samples from patients with AML
    PAS Evans
    MA Short
    AS Jack
    DR Norfolk
    JA Child
    CR Shiach
    F Davies
    K Tobal
    JA Liu Yin
    GJ Morgan
    Leukemia, 1997, 11 : 364 - 369
12345